PROC (Procaps Group S.A.) Earnings per share growth rate in current year
The annual earnings per share volatility of Procaps Group S.A. (PROC) demonstrates the maturity stage of a business focused on US expansion. High-tech cGMP plants in Brazil, Colombia, and the US ensure stability, while specialized temperature-controlled logistics guarantee supply reliability. The value of 0.00 sets the current metric, allowing investors to assess capital density and the risk of a drawdown during prolonged revenue consolidation.
Analytical breakdowns and data insights for company Procaps Group S.A. (PROC)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Procaps Group S.A.|PROC - Long-Term Debt to Equity|Current Liabilities to Capital procapsgroup.com|PROC - Company Aggregate Debts|Debt to Book Value Procaps Group Corp|PROC - Company Long-Term Debts|Company Short-Term Debts Procaps|Critical Liquidity Ratio procapsgroup.com
- net income and valuation multiples indicators:
PROC - Company Net Income|Company Profit Forecast Procaps Group S.A.|PROC - Price to Earnings Ratio|Future Price to Earnings Multiple Procaps Group Corp|PROC - PEG Multiple|Enterprise Value to EBITDA Multiple Procaps Group Corp|PROC - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Procaps|PROC - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months procapsgroup.com|PROC - Net earnings per share growth this year|Earnings growth forecast for next year Procaps Group S.A.
Fundamental valuation:PROC, Procaps Group
Procaps Group S.A. (PROC) maintains operational resilience through its stable engineering potential in Latin America. The eps_yy_co metric converts these achievements into a percentage deviation of current earnings per share compared to the same period last year, measuring the rate of profit capitalization. A positive vector confirms the strategy's effectiveness, while fluctuations in annual EPS signal the impact of personnel reshuffles within the finance department.
Direct competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings per share growth in current year Amneal AMRX|PRGO (Perrigo Company PLC) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Earnings per share increase in current year LQDA (Liquidia Inc.)|Galapagos NV (GLPG) - Earnings per share growth in current year|Earnings per share growth rate in current year anipharmaceuticals.com (ANIP)|MNKD (MannKind) - Earnings growth in current year|Net earnings per share growth this year Amphastar Pharmaceuticals Inc (AMPH)|Earnings growth in current year PCRX|Earnings growth in current year ARS Corp (SPRY)|Earnings per share growth in current year Theravance Biopharma TBPH|AQST (aquestive.com) - Earnings per share trend in current year|SCPH - Earnings per share growth in current year|Expected net earnings per share growth this year Tectonic Therapeutic, Inc. TECX|TNXP (Tonix Pharmaceuticals Inc.) - Net earnings per share growth this year|China SXT Pharmaceuticals, Inc. - Earnings per share increase in current year|EPRX (Eupraxia Pharmaceuticals, Inc.) - Earnings growth in current year|BHST - Net earnings per share change in current year|Earnings per share growth in current year eXoZymes (EXOZ)|ORMP (oramed.com) - Earnings per share increase in current year|Earnings per share growth in current year Entera Bio ENTX|MindWalk Therapeutics (HYFT) - Earnings per share growth rate in current year|ABVC: Net earnings per share growth this year|CPIX - Earnings growth in current year|Quantum BioPharma (QNTM) - Earnings per share growth in current year|Earnings per share trend in current year FGEN (FibroGen Inc)|Net earnings per share growth this year TELO|RANI: Earnings per share increase in current year|Earnings per share growth in current year Synergy CHC Corp (SNYR)|Expected net earnings per share growth this year rallybio.com|Lexaria Bioscience Corp. - Net earnings per share growth this year|Expected net earnings per share growth this year Pulmatrix Inc (PULM)|Pheton - Earnings growth in current year|APM - Earnings growth in current year|LYRA (Lyra Therapeutics, Inc.) - Net earnings per share growth this year|IBO - Expected net earnings per share growth this year|Earnings per share growth in current year TNF Pharmaceuticals Inc.|cbdMD Corp - Earnings per share trend in current year|Earnings per share growth in current year PainReform Limited (PRFX)|CYTO (altamiratherapeutics.com) - Earnings per share increase in current year|Earnings per share growth in current year Lipella Pharmaceuticals LIPO|optinose.com (OPTN) - Earnings per share growth rate in current year|Pieris Pharmaceuticals, Inc. - Earnings growth in current year|Petros Pharmaceuticals Inc (PTPI) - Net earnings per share growth this year|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|Earnings per share trend in current year SLRN (ACELYRIN Inc.)|TFFP (TFF Pharmaceuticals) - Earnings growth in current year
